BIRC3 and glioblastoma: BIRC3, an inhibitor of apoptosis protein by inhibiting caspases cascade, serves as a putative biomarker for patients with oesophageal adenocarcinoma (64) and is associated with therapeutic resistance in glioblastoma and breast cancer cells (65, 66).